Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Rectal Neoplasms 1Oropharyngeal Neoplasms 1Anus Neoplasms 1

Interventions

Early Intervention, Educational 6Oxaliplatin 5Methods 4Cisplatin 4pembrolizumab 3Trastuzumab 3Surveys and Questionnaires 3Specimen Handling 3Leucovorin 3Fluorouracil 3Carboplatin 3X-Rays 2Radiotherapy 2Observation 2Magnetic Resonance Spectroscopy 2Magnetic Resonance Imaging 2Irinotecan 2Interleukin-12 Subunit p35 2Gemcitabine 2Cyclophosphamide 2Counseling 2Cetuximab 2Capecitabine 2Biopsy 2veliparib 1ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1sodium thiosulfate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Epinephrine × Gynecologic × Clear all
NCT04432597 2026-05-18

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
39 enrolled
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡